Robert Lechleider
CIK: 0001997584
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Immunome Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jul 23, 2026IMNM
Immunome Inc.
Award(A)Direct54K shares- - Jul 2, 2026IMNM
Immunome Inc.
Exercise(M)Direct55K shares at avg. $8.73$480K - Jul 2, 2026IMNM
Immunome Inc.
Sale(S)Direct22.7K shares at avg. $21.95$499K - Jul 2, 2026IMNM
Immunome Inc.
Sale(S)Direct16.2K shares at avg. $22.76$369K - Jul 2, 2026IMNM
Immunome Inc.
Sale(S)Direct16.1K shares at avg. $23.44$377K - Jun 25, 2026IMNM
Immunome Inc.
Exercise(M)Direct55K shares at avg. $8.73$480K - Jun 25, 2026IMNM
Immunome Inc.
Sale(S)Direct40.6K shares at avg. $19.56$794K - Jun 25, 2026IMNM
Immunome Inc.
Sale(S)Direct14.4K shares at avg. $20.66$298K - Jul 29, 2025IMNM
Immunome Inc.
Award(A)DirectEmployee Stock Option (right to buy)
242K shares- - Nov 21, 2024IMNM
Immunome Inc.
Purchase(P)Direct15.8K shares at avg. $9.48$150K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 23, 2026 | IMNM Immunome Inc. | Award(A) | 54,000 | - | $0 | Direct |
| Jul 2, 2026 | IMNM Immunome Inc. | Exercise(M) | 55,000 | $8.73 | $480,150 | Direct |
| Jul 2, 2026 | IMNM Immunome Inc. | Sale(S) | 22,714 | $21.95 | $498,572 | Direct |
| Jul 2, 2026 | IMNM Immunome Inc. | Sale(S) | 16,214 | $22.76 | $369,031 | Direct |
| Jul 2, 2026 | IMNM Immunome Inc. | Sale(S) | 16,072 | $23.44 | $376,728 | Direct |
| Jun 25, 2026 | IMNM Immunome Inc. | Exercise(M) | 55,000 | $8.73 | $480,150 | Direct |
| Jun 25, 2026 | IMNM Immunome Inc. | Sale(S) | 40,580 | $19.56 | $793,745 | Direct |
| Jun 25, 2026 | IMNM Immunome Inc. | Sale(S) | 14,420 | $20.66 | $297,917 | Direct |
| Jul 29, 2025 | IMNM Immunome Inc. | Award(A) Employee Stock Option (right to buy) | 242,000 | - | - | Direct |
| Nov 21, 2024 | IMNM Immunome Inc. | Purchase(P) | 15,805 | $9.48 | $149,800 | Direct |
1-10 of 10 transactions
About Lechleider Robert
Lechleider Robert (SEC CIK 0001997584) files insider reports with the SEC as Chief Medical Officer of Immunome Inc. (IMNM).
Signal8 holds 5 ownership filings by Lechleider Robert, all Form 4s, filed between Nov 25, 2024 and Jul 27, 2026. Those filings report 10 transactions, from Nov 21, 2024 to Jul 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lechleider Robert's filings is in BOTHELL, WA.
Recent filings by Lechleider Robert
- Jul 23, 2026: Grant or award of IMNM shares (Form 4, code A).
- Jul 2, 2026: Option exercise of IMNM shares (Form 4, code M).
- Jul 2, 2026: Open-market sales of IMNM shares (3 lines, Form 4, code S).
- Jun 25, 2026: Option exercise of IMNM shares (Form 4, code M).
- Jun 25, 2026: Open-market sales of IMNM shares (2 lines, Form 4, code S).
Other insiders filing for Immunome Inc. (IMNM)
- Higgins Jack, Chief Scientific Officer
- Barchas Isaac, Director
- Horn Kinney, CHIEF BUSINESS OFFICER
- Tsai Philip, Chief Technical Officer
- Stoneman Sandra G., CHIEF LEGAL OFFICER & GC
- Rosett Max, Chief Financial Officer